drugset / Trial / NCT06022588

Chronic Mesenteric Ischemia Breath Testing

NCT06022588 ↗

Completed 20 enrolled Erasmus Medical Center
RandomizedSingle-groupOpen-labelDiagnostic

Summary

Background and aims: A gold standard diagnostic test to diagnose chronic mesenteric ischemia is currently lacking. Isotope labelled-butyrate and glucose breath testing could theoretically quantify mucosal oxygen consumption and thereby detect ischemia, since oxygen is needed to absorb and metabolize butyrate and glucose, and distinguish aerobic/anaerobic intestinal epithelial metabolism. Here we aim to test this notion and compare results to conventional biomarkers. Methods: Healthy volunteers were randomized into two control groups and two intervention groups, each consisting of five volunteers receiving either oral 13C -butyrate or 13C -glucose. The control groups performed breath tests without any physical exercise. The intervention groups performed a 30 minutes standardized bicycle exercise test, which has been proven to elicit mesenteric ischemia. Breath samples of expired 13CO2 were collected during a period of 4 hours and results were contrasted to measurements of biomarkers in peripheral blood.

Timeline

Start
2021-03-01
Primary completion
2021-04-01
Completion
2021-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject 13C D-Glucose Diagnostic / imaging agent 0.75 g Oral
Subject Sodium butyrate Diagnostic / imaging agent 0.8 g Oral